STOCKHOLM, Aug. 4, 2023 /PRNewswire/ — Skanska has finalized a contract with Seagen to construct a 25,000 square meter biomanufacturing facility for the global biotechnology company. The facility will include manufacturing, storage, shipping, office, and café space in Everett, Washington, USA. The contract is worth USD 215 M, about SEK 2.25 billion, which will be included in the U.S. order bookings for the third quarter, 2023. 

Seagen announced their plans to build the project in April 2022. Construction is underway and completion is anticipated for Q4, 2024.

For further information please contact:

Daniela Arellano, Communications Director, Skanska USA, tel +1 213 317 4977

Olof Rundgren, Media Relations Manager, Skanska AB, tel +46 (0)10 448 67 94

Direct line for media, tel +46 (0)10 448 88 99

This and previous releases can also be found at www.skanska.com.

The following files are available for download:

View original content:https://www.prnewswire.com/news-releases/skanska-signs-contract-with-seagen-to-build-facility-in-washington-usa-for-usd-215-m-about-sek-2-25-billion-301893406.html

SOURCE Skanska

Featured image: Megapixl © Rido

Disclaimer